Vimpat
Recall
|
Medicines
|
15/09/2011
The marketing authorization holder, in agreement with the European Medicines Agency (EMA), has informed its supplied customers by fax dated September 14 that all batches of Vimpat Syrup are being recalled. The reason for this recall is precipitation of the active ingredient observed in some batches of the syrup.
Note: Please also refer to the Institute Pharmacovigilance safety information dated July 22, 2011 regarding Vimpat (lacosamide).
| Name of the medicinal product | Vimpat 15 mg/ml Sirup |
|---|---|
| Marketing authorisation number(s) | EU/1/08/470/014-015 |
| Marketing authorisation holder | UCB S.A., BE Durchführung Rückruf: UCB Pharma GmbH, AT |
| Batch number(s) | Alle |
| Expiry date | 09/04/2019 |
| Classification of the recall | 2 |
| BASG reference number | INS-640.001-0186 |
Further inquiry note
Page last modified:
12/07/2022